chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a Certified Medical Assistant refers to an unspecified number of patients of unknown age and gender. The reporter stated that doses of vaccines GARDASIL (dose, route and lot# not reported) that were exposed to a supported temperature excursion that occurred on 29-JUL-2014 had been administered to unspecified patients on unspecified dates. The reporter reported that she had not been informed of any adverse effects. It was unknown if the patients sought medical attention or not. At the time of report, the status of patients was unknown. This is one of the several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a Certified Medical Assistant refers to an unspecified number patients of unknown age and gender. The reporter stated that doses of vaccines RECOMBIVAX HB (dose, route and lot# not reported) that were exposed to a supported temperature excursion that occurred on 29-JUL-2014 had been administered to unspecified patients on unspecified dates. The reporter reported that she had not been informed of any adverse effects. It was unknown if the patients sought medical attention or not. At the time of report, the status of patients was unknown. This is one of the several reports received from the same reporter. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Dizziness, Neck pain, Pyrexia, X-ray
Clinical narrative: DIZZINESS, FEVER AND NECK PAIN.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Fatigue, Headache, Injection site pain, Myalgia
Clinical narrative: Violent chills, fatigue, muscle aches, severe headache, nausea. Pain at injection site, soreness.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea
Clinical narrative: Violent chills, fatigue, muscle aches, severe headache, nausea. Pain at injection site, soreness.
Age: 36.0
Sex: F
Vaccine: TDAP
Symptoms: Carpal tunnel syndrome, Exposure during pregnancy, Pain in extremity
Clinical narrative: Likely carpel tunnel symptoms got much worse; acute pain when arm is stretched.
Age: 62.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Influenza like illness, Pain, Pyrexia
Clinical narrative: Sudden onset of very severe classic flu-like symptoms, particularly uncontrollable shivering, followed a few hours later by sensation of running a high fever. Also general body aching. I receive a flu shot every year and always have a very mild reaction, but never anything like this! Aspirin did not mitigate the symptoms. I made every effort to remain hydrated.
Age: 12.0
Sex: M
Vaccine: VARCEL
Symptoms: Incorrect dose administered, Injection site vesicles
Clinical narrative: This spontaneous report as received from a nurse refers to a 12 year old male patient without any pertinent medical history and drug reactions or allergies. On an unknown date in 2004, the patient was vaccinated with the first dose of (Oka/Merck) VARIVAX 0.5 ml, subcutaneous (lot number was not reported). On an unknown date in 2007, the patient was vaccinated with the second dose of (Oka/Merck) VARIVAX (dose, strength frequency, route and lot number were not reported). On 22-AUG-2014, the patient was vaccinated with the third dose of (Oka/Merck) VARIVAX (vial 1350 U) lot # J013905, expiration date 30-OCT-2015 in the arm (dose, strength and route were not reported). The nurse reported that the patient received a third dose of (Oka/Merck) VARIVAX due to lack of documentation of the second dose of (Oka/Merck) VARIVAX at the time of the office visit. Patient developed a blister or vesicle on his arm at the injection site after receiving the dose of (Oka/Merck) VARIVAX ON 22-AUG-2014. The outcome of blister or vesicle at the injection site was not reported. No treatment was given for the adverse event. No lab diagnostics studies were performed. It was reported that the patient seek medical attention by an unspecified method. This is one of two reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse. The nurse stated doses of RECOMBIVAX HB (doses unspecified in series) were administered between 24-JUL-2014 and 01-AUG-2014, doses were exposed to -1.5 C for 5 hours. No adverse effects reported. Nurse stated she had no patient specific information. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report as received from a physician via a company representative and refers to a female patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX injection, subcutaneous (dose, units, anatomical location, lot number were not reported). On an unknown date, after receiving ZOSTAVAX the patient was diagnosed with the shingles. There was no treatment given for the adverse event. The patient sought medical attention via visiting an office on an unspecified date. The outcome of adverse event was not reported. The relatedness between event and ZOSTAVAX was not reported. Additional information is not expected because the physician refused to be contacted.
Age: 74.0
Sex: F
Vaccine: HEP, PPV
Symptoms: Respiratory arrest
Clinical narrative: This spontaneous report as received from a Nurse practitioner refers to a female patient of 74 years of age. The patient's concurrent condition included asthma and hypertension. The patient's drug reactions/allergies were reported for penicillin, prednisone, ZANTAC, TAGAMET, PEPCID, PREVACID, DILAUDID. On an unknown date, the patient was vaccinated with hepatitis b vaccine (manufacturer unknown) (dose, route and lot number not reported). Concomitant therapies included TOPROL, CLARITIN, FLOVENT and hydrocodone. On an unknown date, the patient experienced respiratory arrest after receiving hepatitis b vaccine (manufacturer unknown). The patients present status was reported as recovered (date unspecified). The patient sought of medical attention. No product quality complaint (PQC) was reported. Upon internal review, the event respiratory arrest was determined to be medically significant. On an unspecified date, patient experienced local reaction after receiving pneumococcal vaccine (manufacturer unknown) (reported in MARRS # 1409USA004713/same patient link). Additional information has been requested.
Age: 74.0
Sex: F
Vaccine: HEP, PPV
Symptoms: Local reaction
Clinical narrative: This spontaneous report as received from a Nurse practitioner refers to a female patient of 74 years of age. The patient's concurrent condition included asthma and hypertension. The patient's drug reactions/allergies were reported for penicillin, prednisone, ZANTAC, TAGAMET, PEPCID, PREVACID, DILAUDID. On an unknown date, the patient was vaccinated with hepatitis b vaccine (manufacturer unknown) (dose, route and lot number not reported). Concomitant therapies included TOPROL, CLARITIN, FLOVENT and hydrocodone. On an unknown date, the patient experienced respiratory arrest after receiving hepatitis b vaccine (manufacturer unknown). The patients present status was reported as recovered (date unspecified). The patient sought of medical attention. No product quality complaint (PQC) was reported. Upon internal review, the event respiratory arrest was determined to be medically significant. On an unspecified date, patient experienced local reaction after receiving pneumococcal vaccine (manufacturer unknown) (reported in MARRS # 1409USA004713/same patient link). Additional information has been requested.
Age: 0.21
Sex: U
Vaccine: HEP
Symptoms: Incorrect dose administered, No adverse event, Wrong drug administered
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age. The patient's medical history and current condition are not reported. It was reported that on 03-SEP-2014 the patient was vaccinated with RECOMBIVAX HB and PEDIARIX, intramuscularly. Also reported that the patient received PEDIARIX instead of the LIQUDI PEDVAXHIB. No adverse effects reported. Product quality complaint was not involved. The outcome of the event is unknown. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report was received from a pharmacist concerning to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 04-SEP-2014, the patient was vaccinated with a dose of ZOSTAVAX (dose, dose number and route were not reported) lot # J011212, expiration date 29-AUG-2014. Co-suspect concomitant therapies were not reported. The pharmacist reported that patient received expired dose of ZOSTAVAX on 04-SEP-2014. No adverse effect was reported. Additional information has been requested.
Age: 40.0
Sex: U
Vaccine: VARZOS
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist via a company representative refers to a 40 year old patient. Medical history and concurrent conditions were not reported. On an unknown date the patient was vaccinated with ZOSTAVAX. Dose, route, lot number and expiration date were not reported. No co-suspect and concomitant therapies were reported. The pharmacist reported that he administered ZOSTAVAX to a 40 year old patient. No adverse effect reported. Additional information is not expected. No allowed to contact physician.
Age: 54.0
Sex: F
Vaccine: VARZOS, FLU3, VARZOS, FLUX, VARZOS
Symptoms: Back pain, Condition aggravated, Injection site cellulitis
Clinical narrative: This spontaneous report as received from a 54 year old female consumer with back pain since approximately August 2013 and allergy to erythromycin (reaction, dates and manufacturer unspecified), refers to herself. No pertinent medical history was provided. On about 25-AUG-2014, the patient was vaccinated with ZOSTAVAX, subcutaneously (dose and lot number not provided). No co-suspect therapies were reported. Concomitant therapies included hydrocodone/APAP, and Influenza virus vaccine (unspecified). On about 26-AUG-2014, the patient developed cellulitis at the site of ZOSTAVAX injection. On 29-AUG-2014, the patient was started on cephalexin (manufacturer unspecified) for the cellulitis. On 02-SEP-2014, the patient developed a sudden worsening of the pain in her back. The patient sought medical attention, she went to see a physician. No lab diagnostic studies were performed. At the time of the report, the patient had not recovered from the worsened back pain and was recovering from the cellulitis. Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: VARZOS, FLU3, VARZOS, FLUX, VARZOS
Symptoms: Injection site infection
Clinical narrative: This spontaneous report as received from a 54 year old female consumer with back pain since approximately August 2013 and allergy to erythromycin (reaction, dates and manufacturer unspecified), refers to herself. No pertinent medical history was provided. On about 25-AUG-2014, the patient was vaccinated with ZOSTAVAX, subcutaneously (dose and lot number not provided). No co-suspect therapies were reported. Concomitant therapies included hydrocodone/APAP, and Influenza virus vaccine (unspecified). On about 26-AUG-2014, the patient developed cellulitis at the site of ZOSTAVAX injection. On 29-AUG-2014, the patient was started on cephalexin (manufacturer unspecified) for the cellulitis. On 02-SEP-2014, the patient developed a sudden worsening of the pain in her back. The patient sought medical attention, she went to see a physician. No lab diagnostic studies were performed. At the time of the report, the patient had not recovered from the worsened back pain and was recovering from the cellulitis. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: TDAP
Symptoms: Unevaluable event
Clinical narrative: No.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Basophil percentage increased, Blood chloride decreased, Blood chloride increased, Blood cholesterol increased, Blood creatine phosphokinase MB increased
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Blood creatine phosphokinase MB normal, Blood creatine phosphokinase increased, Blood creatinine increased, Blood glucose increased, Blood magnesium increased
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Blood phosphorus normal, Blood potassium decreased, Blood thyroid stimulating hormone normal, Blood triglycerides increased, Blood urea increased
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Brain natriuretic peptide increased, Cardiac failure, Cardiomegaly, Cardiomyopathy, Catheterisation cardiac abnormal
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Chest X-ray abnormal, Coronary artery disease, Cough, Coxsackie virus test positive, Cytomegalovirus test positive
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Differential white blood cell count abnormal, Dyspnoea, Dyspnoea paroxysmal nocturnal, Echocardiogram abnormal, Ejection fraction decreased
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Electrocardiogram abnormal, Eosinophil percentage increased, Herpes simplex serology negative, High density lipoprotein decreased, Human herpes virus 6 serology positive
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Influenza A virus test positive, Influenza B virus test positive, Left ventricular dysfunction, Left ventricular hypertrophy, Low density lipoprotein normal
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Metabolic function test normal, Mitral valve incompetence, Myocarditis, Neutrophil percentage decreased, Nuclear magnetic resonance imaging abnormal
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Oedema peripheral, Orthopnoea, Parvovirus B19 test positive, Rhinorrhoea, Right ventricular systolic pressure increased
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Roseolovirus test positive, Troponin I increased, Ventricular hypokinesia, Viral test negative, Weight increased
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: White blood cell count increased
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Basophil percentage increased, Blood chloride decreased, Blood chloride increased, Blood cholesterol increased, Blood creatine increased
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Blood creatine phosphokinase MB increased, Blood creatine phosphokinase increased, Blood glucose increased, Blood magnesium increased, Blood phosphorus normal
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Blood potassium decreased, Blood thyroid stimulating hormone normal, Blood triglycerides increased, Blood urea increased, Brain natriuretic peptide increased
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.
Age: 38.0
Sex: M
Vaccine: FLUC3, FLUC3
Symptoms: Cardiac failure, Cardiomegaly, Cardiomyopathy, Catheterisation cardiac, Chest X-ray abnormal
Clinical narrative: The patient who has a history of poorly controlled hypertension received an Influenza vaccination (FLUCELVAX) on 6/16/14. At the time of vaccination the pt. reported that he had a 2-3 day history of a dry cough and rhinorrhea (with clear discharge). He denied fever, chills, sore throat, earache, diarrhea, nausea or vomiting. He also denied an increase of symptoms or local redness, swelling or pain at the injection site after the vaccination. He did not miss any work due to his symptoms nor did it interfere with his sleep pattern, ADLs or exercise regimen (daily treadmill and weight lifting). The pt. states that the cough and runny nose had completely resolved by 7/1/14. He remained asymptomatic until 7/26/14 when he became uncharacteristically dyspneic after a light swim and walking a few blocks. That night he had 3 pillows orthopnea. He denied chest pain, chest pressure palpitations or lightheadedness. On 7/29/14 after a third night of orthopnea the pt. reported to the clinic. At that time his weight was up about 20-25 pounds and the pt. noted that his ankles were edematous. The pt. was transported by ambulance to Hospital with new onset heart failure. The pt. was diuresed with LASIX over 1-2 days with significant improvement of his symptoms. The pt. was transferred to another facility for further evaluation. The pt. has had an echocardiogram, cardiac cath, and cardiac MRI and is currently being followed by the cardiology clinic. He was recently diagnosed with myocarditis and nonischemic cardiomyopathy. The pt. is wearing a Zoll life vest; the pt. denies any discharges. The patient's current medications are: ASA 81mg qd, COREG 25mg bid, LIPITOR 40mg qd, MICARDIS 80mg qd and Spironolactone 25mg qd, LASIX 20mg qd and Potassium Chloride 20meq qd. He walks approx. 2 miles/day at a leisurely pace without symptoms. He does c/o occasional paroxysmal nocturnal dyspnea. The pt. denies chest pain/discomfort, dyspnea, palpitations, or syncope/presyncope.